Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt

Mohamed El Kassas (1) , Anna Funk (2) , Y. Abd El Latif (3) , Anca Vasiliu (2) , A. Sherief (3) , Yusuke Shimakawa (2) , N. Youssef (4) , A. El Tahan (5) , M. Elbadry (6) , A. Farid (3) , Y. El Shazly (7) , W. Doss (7) , G. Esmat (7) , A. Fontanet (2, 8)

1 Helwan University [Caire]
2 Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology
3 Université Ain Shams
4 Cairo University
5 New Cairo Viral Hepatitis Treatment Unit
6 University of Aswan
7 Egyptian National Committee for Control of Viral Hepatitis
8 PACRI - Pasteur-Cnam Risques infectieux et émergents

Domains: Life Sciences [q-bio]; Santé publique et épidémiologie

Mohamed El Kassas, Anna Funk, Y. Abd El Latif, Anca Vasiliu, A. Sherief, et al.. Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt. Alimentary Pharmacology & Therapeutics (Suppl), 2018, 47 (11), pp.1564-1566. ⟨10.1111/apt.14628⟩. ⟨pasteur-02875242⟩